申请人:Akzo N.V.
公开号:US05258392A1
公开(公告)日:1993-11-02
The invention relates to a 3-quinuclidine derivative having the formula I ##STR1## wherein X is O or S, and R represents one to five substituents independently selected from hydrogen, hydroxy, lower alkyl, lower alkoxy, lower aralkyloxy, lower alkanoyloxy, halogen, NO.sub.2, CF.sub.3, CN, NR.sub.1 R.sub.2, and COR.sub.3, in which R.sub.1 and R.sub.2 are independently selected from hydrogen, lower alkyl, and lower alkanoyl, and R.sub.3 is selected from OH, lower alkyl, lower alkoxy, and NR.sub.4 R.sub.5, wherein R.sub.4 and R.sub.5 are independently hydrogen or lower alkyl; or pharmaceutically acceptable salts thereof.
该发明涉及具有以下式I的3-喹诺啉衍生物
其中X为O或S,R代表一个到五个取代基,独立选择自氢、羟基、较低烷基、较低烷氧基、较低芳基氧基、较低烷酰氧基、卤素、NO.sub.2、CF.sub.3、CN、NR.sub.1 R.sub.2和COR.sub.3,其中R.sub.1和R.sub.2独立选择自氢、较低烷基和较低烷酰基,R.sub.3选择自OH、较低烷基、较低烷氧基和NR.sub.4 R.sub.5,其中R.sub.4和R.sub.5独立选择自氢或较低烷基;或其药学上可接受的盐。